Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
19.38
-0.19 (-0.98%)
Feb 27, 2026, 4:00 PM EST - Market closed
-0.98% (1D)
| Assets | $11.16M |
| Expense Ratio | 0.55% |
| PE Ratio | 19.22 |
| Shares Out | 575,000 |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 0.32% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Ratio | 6.09% |
| 1-Year Return | -1.32% |
| Volume | 236 |
| Open | 19.20 |
| Previous Close | 19.57 |
| Day's Range | 19.20 - 19.38 |
| 52-Week Low | 15.37 |
| 52-Week High | 22.34 |
| Beta | n/a |
| Holdings | 51 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
26.50% of assets| Name | Symbol | Weight |
|---|---|---|
| Enphase Energy, Inc. | ENPH | 3.42% |
| RingCentral, Inc. | RNG | 2.78% |
| Align Technology, Inc. | ALGN | 2.68% |
| Bristol-Myers Squibb Company | BMY | 2.63% |
| Cirrus Logic, Inc. | CRUS | 2.61% |
| Merck & Co., Inc. | MRK | 2.56% |
| F5, Inc. | FFIV | 2.53% |
| Jazz Pharmaceuticals plc | JAZZ | 2.48% |
| BioMarin Pharmaceutical Inc. | BMRN | 2.47% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.34% |
